I have some bad news
The CO teacher who was fired for allegedly forcing girls to make out in class got a new job as an elementary school teacher in Malley Drive Elementary School in @Adams12.
You can contact superintendent Chris Gdowski here: 720-972-4000
🚨WHAT THE HELL?!!!
A mother stepped in front of an armed Black male robber to protect her son…
…AND HE SH0T HER IN THE HEAD AS SHE RAN AWAY!!!!!
Read that again… as she RAN AWAY.
Her name was Jean Gragg, she was 40 years old.
Her son had arranged to sell a watch on Facebook Marketplace.
The buyer came to their own home in South Bend, Indiana.
Police say that 18-year-old buyer, John Ford, pulled out a gun, said “I need it,” and tried to rip the watch out of the son’s hands.
Jean did what a mother does… she stepped BETWEEN them.
She put herself in front of the gun and chased him off her property.
Then, police say, surveillance video shows the coward turning and firing at her MULTIPLE TIMES as she turned around and ran back toward her house.
He sh0t her in the head.
He threw the gun over a fence and ran.
On Saturday, Jean Gragg sadly passed away.
He is now charged with M*RDER.
WE. DO. NOT. HAVE. TO. LIVE. LIKE. THIS!!!!!!!!!
Say her name. Jean Gragg.
A small public service announcement from the Department of Things That You Should Know…
It has not “peeked” your interest.
Nor has it “peaked” your interest.
…It has piqued your interest.
You are not “phased” by something.
You are fazed by it.
If you’ve had a long day, you are weary.
If you suspect someone is an idiot, you are wary.
It is “due course”, not “do course”.
“Per se”, not “per say”.
And while we’re here, it’s “could have”, not “could of”, but that particular battle may already be lost.
Thank you for your attention during this brief outbreak of grammatical housekeeping.
This has been a @LairdofthManor announcement.🎩💙
Three pitchers for the @SFGiants were issued warnings from the @MLB after they wrote Bible verses on their Pride-themed caps, claiming their actions "violate our rules."
The @MLB is discriminating against Christians while promoting degeneracy.
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
It is with deep sadness that I share with you the news that Kerry Sheron, a 69-year-old Army veteran, tragically passed away Sunday night after being brutally beaten by his neighbor, all because he loved our country and President Trump.
Please send all your love and prayers to Kerry’s wife and family on this difficult day.
May God bless his beautiful soul. We thank him for his service to our country. 😔💔